Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Operating Leases (2019 - 2024)

Iradimed has reported Operating Leases over the past 6 years, most recently at $2000.0 for Q4 2024.

  • Quarterly Operating Leases fell 99.88% to $2000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $2000.0 through Dec 2024, down 99.88% year-over-year, with the annual reading at $2000.0 for FY2024, 99.88% down from the prior year.
  • Operating Leases was $2000.0 for Q4 2024 at Iradimed, down from $2831.0 in the prior quarter.
  • Over five years, Operating Leases peaked at $2.7 million in Q1 2020 and troughed at $2000.0 in Q4 2024.
  • The 5-year median for Operating Leases is $2.0 million (2022), against an average of $1.8 million.
  • Year-over-year, Operating Leases decreased 8.44% in 2020 and then crashed 99.88% in 2024.
  • A 5-year view of Operating Leases shows it stood at $2.5 million in 2020, then dropped by 10.32% to $2.2 million in 2021, then fell by 13.32% to $1.9 million in 2022, then fell by 15.52% to $1.6 million in 2023, then crashed by 99.88% to $2000.0 in 2024.
  • Per Business Quant, the three most recent readings for IRMD's Operating Leases are $2000.0 (Q4 2024), $2831.0 (Q3 2024), and $4231.0 (Q2 2024).